Comparison of Treatment Options for Experimental Endometriosis in Rats

article OA: closed CC0
AI-generated summary by claude@2026-07, 2026-07-09

Surgery combined with intraperitoneal application of "Vilon" therapy effectively improved reproductive function parameters in rats with experimental endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-09 · read from full text

The paper assessed the effectiveness of surgery, the immunomodulator “Vilon” administered intraperitoneally, and their combination for treating experimental endometriosis in rats, using reproductive function parameters as outcomes. The experiments found that the combination of surgery plus intraperitoneal “Vilon” was more promising than the other treatment approaches for endometriosis-related reproductive outcomes. A stated caveat is that the evidence is based on an animal model and short experimental comparisons focused on reproductive function rather than broader clinical endpoints. This paper is centrally about endometriosis — it directly compares surgical and immunomodulator-based treatment strategies in a rat model of experimental endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The effectiveness of surgery, immunomodulator "Vilon" therapy, and their combination in the treatment of experimental endometriosis in rats was assessed by the parameters of reproductive function. The experiments demonstrated that surgery combined with intraperitoneal application of "Vilon" is a promising option in the treatment of endometriosis.
Full text 1,431 characters · extracted from oa-doi-fallback · click to expand
The effectiveness of surgery, immunomodulator “Vilon” therapy, and their combination in the treatment of experimental endometriosis in rats was assessed by the parameters of reproductive function. The experiments demonstrated that surgery combined with intraperitoneal application of “Vilon” is a promising option in the treatment of endometriosis. Similar content being viewed by others References I. Yu. Sharabanova, A. O. Nazarova, A. L. Palkin, and S. B. Nazarov, Vestn. Ivanovsk. Med. Akad., 7, Nos. 1–2, 37–39 (2002). R. Gazvani and A. Templeton, Int. J. Gynaecol. Obstet., 76, No. 2, 117–126 (2002). T. Harada, T. Iwabe, and N. Terakawa, Fertil. Steril., 76, No. 1, 1–10 (2001). A. W. Nap, P. G. Groothuis, A. Y. Demir, et al., Best. Pract. Res. Clin. Obstet. Gynaecol., 18, No. 2, 233–244 (2004). M. W. Vernon and E. A. Wilson, Fertil. Steril., 44, No. 5, 684–694 (1985). Author information Authors and Affiliations Corresponding author Additional information Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 158, No. 11, pp. 632–634, November, 2014 Rights and permissions About this article Cite this article Aleksinskaya, E.S., Nazarov, S.B., Posiseeva, L.V. et al. Comparison of Treatment Options for Experimental Endometriosis in Rats. Bull Exp Biol Med 158, 681–683 (2015). https://doi.org/10.1007/s10517-015-2834-8 Received: Published: Issue date: DOI: https://doi.org/10.1007/s10517-015-2834-8

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Animals Dipeptides Dipeptides Endometriosis Female Immunologic Factors Immunologic Factors Injections, Intraperitoneal Rats Rats, Wistar

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

References (5)

Source provenance

europepmc
last seen: 2026-08-08T06:08:32.324769+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:17:58.238279+00:00
License: CC0 · commercial use OK